| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 5 securities · passive | ||||||
|
ClearThink 1 Acquisition Corp.
13G
CTAA · G2294A101
|
8.4% |
7/20/2026
Event 6/30/2026
|
||||
| Mangrove Partners IM, LLC | 8.4% | |||||
| Nathaniel August | 8.4% | |||||
|
ChampionsGate Acquisition Corporation
13G/A
CHPG · G2124S108
|
2.8% |
7/20/2026
Event 6/30/2026
|
||||
| Mangrove Partners IM, LLC | 2.8% | |||||
| Nathaniel August | 2.8% | |||||
|
Mereo BioPharma Group plc
13G/A
MREO · 589492107
|
4.9% |
11/14/2025
Event 9/30/2025
|
||||
| Mangrove Partners IM, LLC | 4.9% | |||||
| Nathaniel August | 4.9% | |||||
|
Anebulo Pharmaceuticals, Inc.
13G
ANEB · 034569103
|
6.2% |
3/17/2025
Event 12/31/2024
|
||||
| Mangrove Partners IM, LLC | 6.2% | |||||
| Nathaniel August | 6.2% | |||||
|
Arogo Capital Acquisition Corp.
13G/A
AOGO · 042644104
|
4.5% |
1/8/2025
Event 12/31/2024
|
||||
| Mangrove Partners IM, LLC | 4.5% | |||||
| Nathaniel August | 4.5% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.